Tuesday, December 2, 2025
10 C
London

Tag: Emyria

Emyria: Reveals “strong recruitment” for EMD-RX5 phase IIItrial

Emyria Reveals “strong recruitment” for EMD-RX5 phase IIItrial Emyria (EMD) announces “strong recruitment” in a phase III clinical trial...

Emyria: Raises $3m for clinical trials

Emyria Raises $3m for clinical trials Clinical-stage biotech company Emyria (EMD) has received firm commitments to raise $3 million...

Emyria: Expands drug candidate library with fourth batch of MDMA-inspired analogues

Emyria Expands drug candidate library with fourth batch of MDMA-inspired analogues Emyria (EMD) progresses its pre-clinical MDMA-inspired drug discovery...

Emyria: Receives positive screening results for MDMA-inspired analogues

Emyria Receives positive screening results for MDMA-inspired analogues Emyria (EMD) receives positive screening results from its MDMA novel drug...

Emyria: Expands drug candidate library with third batch of MDMA-inspired analogues

Emyria Expands drug candidate library with third batch of MDMA-inspired analogues Emyria (EMD) progresses its drug discovery and development...

Emyria: Appoints Sixty Two Capital as corporate advisor for next phase of growth

Emyria Appoints Sixty Two Capital as corporate advisor for next phase of growth Emyria (EMD) appoints Sixty Two Capital...

Emyria: Receives positive initial MDMA-analogue screening results

Emyria Receives positive initial MDMA-analogue screening results Emyria (EMD) receives positive results from the first batch of MDMA analogues...

Emyria: Receives TGA approval for Openly heart rate monitoring app

Emyria (EMD) has received Therapeutic Goods Administration (TGA) approval for its Openly app, which will used in several...

Emyria: Wins digital health monitoring grant

Emyria's (EMD) remote monitoring service Openly will provide advanced digital and mental health monitoring as part of a...